Total raised
$7.0M
Last: Series C 2014-09
Stage
Series C
Founded
2007
Headcount
3
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
GluSense is developing Glyde CGM, a miniature, implantable, continuous glucose sensor. The sensor is designed to be implanted under the skin and can transmit continuous glucose values to an external unit or smartphone for over a year, significantly improving the quality of life for patients with diabetes. The sensor is composed of a sensing unit which detects glucose and provides a glucose-dependent optical signal using a biosensor, and a detection unit which reads the optical signals and transmits the data to the external unit. GluSense is part of the Rainbow Medical innovation house.
Funding history · 2 rounds · $7.0M total
2014-09
Series C
$5.0M
Date unknown
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote Monitoring
Technologies
Platforms & InterfacesMobileSensingMaterials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2BB2B2C
Highlights
1 PatentsVerified
Tags
digital-healthcaremedical-devicesdiabetessensorsmonitoringmhealthmobile-applicationsremote-monitoringhealthcare-providerschronic-patientsoptronicsmedical-technologiesbioconvergence